Acta Vet. Brno 2015, 84: 237-242
https://doi.org/10.2754/avb201584030237
Plasma amylin concentration in suckling goat neonates and its relationship with C-reactive protein, selected biochemical and hormonal indicators
References
1. Altman DG 1991: Practical statistics for medical research. London: Chapman and Hall, London, 423 p.
2. N, Carlo WA, D’Angio CT, McDonald SA, Das A, Schendel D, Thorsen P, Higgins RD 2009: Cytokines associated with bronchopulmonary dysplasia or death in extremely low birth weight infants. Pediatrics 123: 1132-1141
<https://doi.org/10.1542/peds.2008-0526>
3. G 2005: Effects of meal ingestion on plasma amylin concentration in NIDDM and non diabetic humans. Diab Med 6: 752-756
4. M, Wolińska-Witort E, Martyńska L, Baranowska B 2005: Effect of amylin on prolactin release. Neuroendocrinol Lett 26: 680-684
5. TP, Goldberg M, Odom R, Stolpe M 1992: In vitro effects of amylin on carbohydrate metabolism in liver cells. Diabetes 41: 975-981
<https://doi.org/10.2337/diab.41.8.975>
6. G, Caruso A, Cutuli VM, Prato A,de Bemardis E, Fiore CE, Amico-Roxas M 1995: Anti-inflammatory activity of amylin and CGRP in different experimental models of inflammation. Life Sci 57: 193-197
<https://doi.org/10.1016/0024-3205(95)02100-W>
7. European Union Directive 2003/65/EC of the European Parliament and of the Council of 22 July 2003 amending Council Directive 86/609/EEC on the approximation of laws, regulations and administrative provisions of the member states regarding the protection of animals used for experimental and other scientific purposes (text with EEA relevance), Official Journal of the European Union L 230, 2003, pp 32-33
8. G, Hernandez C, Simo R 2006: Serum markers of vascular inflammation in dyslipemia. Clin Chim Acta 369: 1-16
<https://doi.org/10.1016/j.cca.2005.12.027>
9. BD, Cox LM, Carlson CD, May PC 2000: Human amylin stimulates inflammatory cytokine secretion from human glioma cells. Neuroimmunomodulation 7: 147-152
<https://doi.org/10.1159/000026432>
10. J 2009: Neonatal energy substrate production. Indian J Med Res 130: 618-623
11. ZX, Sun ZH, Yang WZ, Beauchemin KA, Tang SX, Zhou CS, Han XF, Wang M, Kang JH, Tan ZL 2014: Effects of maternal protein or energy restriction during late gestation on immune status and responses to lipopolysaccharide challenge in postnatal young goats. J Anim Sci 92: 4856-4864
<https://doi.org/10.2527/jas.2014-7904>
12. A, Awadalla M, El-Batrawy S, Abdel-Mageed A, Eleswed A 2009: Amylin hormone, leptin and other metabolic hormones in preterm babies. Res J Med and Med Sci 4: 415-420
13. JW, Ahren B, Lips CJ 2000: Islet amyloid and type 2 diabetes mellitus. N Engl J Med 343: 411-419
<https://doi.org/10.1056/NEJM200008103430607>
14. MN, Chanteranne B, Lebecque P, Davicco MJ, Coxam V, Young A 2001: Amylin and bone metabolism in streptozotocin-induced diabetic rats. J Bone Miner Res 16: 958-965
<https://doi.org/10.1359/jbmr.2001.16.5.958>
15. X, Sun L, Li Z, Mou H, Yu Z, Li H, Jiang P, Yu D, Wu H, Ye X, Lin X, Le Y 2011: Associations of amylin with inflammatory markers and metabolic syndrome in apparently healthy Chinese. PloS ONE 6(9): e24815
<https://doi.org/10.1371/journal.pone.0024815>
16. V, Deorukhkar A, Coombs R, Fraser R, Mayer T 2005: Amylin peptide levels are raised in infants of diabetic mothers. Arch Dis Child 90: 1279-1282
<https://doi.org/10.1136/adc.2005.078238>
17. E, Sandler S 2001: Islet amyloid polypeptide promotes beta-cell proliferation in neonatal rat pancreatic islets. Diabetologia 44: 1015-1018
<https://doi.org/10.1007/s001250100601>
18. B, Cooper GJ 1988: Pancreatic amylin and calcitonin gene-related peptide cause resistance to insulin in skeletal muscle in vitro. Nature 335: 632-635
<https://doi.org/10.1038/335632a0>
19. DG, Ballard OA, Hughes MA, Morrow AL, Horseman ND, Nommsen-Rivers LA 2013: RNA Sequencing of the human milk fat layer transcriptome reveals distinct gene expression profiles at three stages of lactation. PLos ONE 8(7): e67531
<https://doi.org/10.1371/journal.pone.0067531>
20. T 2005: Pancreatic amylin as a centrally acting satiety hormone. Current Drug Targets 6: 181-189
<https://doi.org/10.2174/1389450053174596>
21. AV, Butler PC 2006: Beta-cell deficit due to increased apoptosis in the human islet amyloid polypeptide transgenic (HIP) rat recapitulates the metabolic defects present in type 2 diabetes. Diabetes 55: 2106-2114
<https://doi.org/10.2337/db05-1672>
22. C, Ehren E, Bolme P, Amer P 1988: Regulation of lipolysis during the neonatal period. Importance of thyrotropin. J Clin Invest 82: 1793-1797
<https://doi.org/10.1172/JCI113793>
23. L, Mold C, Du Clos TW 2005: C-reactive protein: ligands, receptors and role in inflammation. Clin Immunol 117: 104-111
<https://doi.org/10.1016/j.clim.2005.08.004>
24. AP, Durward A, Turner C 2002: Amylin is associated with delayed gastric emptying in critically ill children. Intensive Care Med 28: 336-340
<https://doi.org/10.1007/s00134-002-1224-7>
25. SH, Farr VC, Lee J, Prosser CG, Cooper GJ, Davis SR 1999:Metabolic effects of amylin in lactating goats. J Anim Sci 177: 1241-1248
<https://doi.org/10.2527/1999.7751241x>
26. H, Ekelund M, Ekblad E, Sundler F 1997: Islet amyloid polypeptide in the gut and pancreas: localization, ontogeny and gut motility effects. Peptides 18: 771-783
<https://doi.org/10.1016/S0196-9781(97)00008-9>
27. B, Moller N, Gravholt CH, Orskov L, Mengel A, Bryan G, Moyses C, Alberti KG, Schmitz O 1996: Acute effects of the human amylin analog AC137 on basal and insulin-stimulated euglycemic and hypoglycemic fuel metabolism in patients with insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 81: 1083-1089
28. A, Rittenhouse J, Trainor D 1996: Development of sensitive immunoassays to detect amylin and amylin-like peptides in untreated plasma. Clin Chem 42: 576-85
<https://doi.org/10.1093/clinchem/42.4.576>
29. T, De Sousa G, Niklowitz P, Roth CL 2007: Amylin and its relation to insulin and lipids in obese children before and after weight loss. Obesity 15: 2006-2011
<https://doi.org/10.1038/oby.2007.239>
30. M, El-Kabbany MF, Abeer MA, Samah Eid 2013: Inflammatory markers as laboratory tool for early diagnosis of subclinical mastitis in goats with special reference to their effect on the milk quality. Zag Vet J 41: 171-178
31. D, Mamo JC 2000: Islet amyloid polypeptide (amylin) modulates chylomicron metabolism in rats. Clin Exp Pharmacol Physiol 27: 345-351
<https://doi.org/10.1046/j.1440-1681.2000.03255.x>
32. MM, Desoky A, Abdel Hamid OM, Shabaan Z 2011: Acute phase proteins, immunoglobulins and cytokines responses to amylin injection in Wister rats. Global J Biochem Biotechnol 6: 112-118
33. R, Sanke T, Hirayama J, Tabata H, Furuta H 1990: Islet amyloid polypeptide amide causes peripheral insulin resistance in vivo in dogs. Diabetologia 33: 118-120
<https://doi.org/10.1007/BF00401051>
34. M, Kalamaras J, German, M 2002: Expression of IAPP and prohormone convertase 1/3 reveals adistinctive set of endocrine cells in the embryonic pancreas. Mech Dev 115: 171-176
<https://doi.org/10.1016/S0925-4773(02)00118-1>
35. P, Tikellis C, Nobes M, Casley D, Cooper M, Darby I 1988: Amylin as a growth factor during fetal and postnatal development of the rat kidney. Kidney Int 53: 25-30
<https://doi.org/10.1046/j.1523-1755.1998.00722.x>
36. JM, Lim-Fraser M, Cooney GJ, Cooper GJ, Iglesias MA 2001: Evidence that amylin stimulates lipolysis in vivo: a possible mediator of induced insulin resistance. Am J Physiol Endocrinol Metab 280: 562-569
<https://doi.org/10.1152/ajpendo.2001.280.4.E562>
37. M, Shankar VS, Huang CLH, Pazianas M, Bloom SR 1993: Amylin in bone conservation- current evidence and hypothetical considerations. Trends Endocrinol Metab 4: 255-259
<https://doi.org/10.1016/1043-2760(93)90095-V>
